Pharma & Biotech

Immunovant Inc. has jolted the biotechnology sector with compelling long-term results for its lead drug candidate, batoclimab, in treating Graves'...

Eli Lilly has gained significant competitive advantage in the development of innovative cancer therapies following a crucial regulatory decision by...

Assembly Biosciences' stock remains entrenched in a pronounced bearish phase, with investor sentiment staying decidedly negative despite recent corporate developments....

As markets resumed activity following the extended holiday weekend, Protara Therapeutics presented investors with a complex financial picture. The company...

The company formerly known as IsoRay has undergone a significant transformation. Following its merger with Viewpoint Molecular Targeting, the entity...

While most market observers focus on quarterly earnings and product pipelines, a significant strategic development is unfolding in Indianapolis that...

Biotechnology firm Century Therapeutics has initiated a dramatic corporate restructuring, eliminating nearly half of its workforce and replacing key executives....

The biotechnology sector is bracing for a pivotal event as aTyr Pharma approaches the release of critical Phase 3 clinical...

Shares of Crescent Biopharma, the company formerly operating as Catalyst Biosciences, are experiencing notable upward momentum today. The stock has...

Viking Therapeutics shares encountered selling pressure as the market digested Phase II trial data for its oral obesity treatment candidate...